SS/SB 1605 - This act makes 7-hydroxymitragynine (7-OH) in amounts concentrated at a level above 1,000 parts per million on a dry-weight basis a Schedule I controlled substance.
This provision is substantially similar to HB 1614 (2026).
Additionally, this act prohibits the preparation, distribution, advertisement, sale, or offering for sale of a kratom product that: (1) is adulterated; (2) is sold to a person under 21 years of age; (3) contains 7-hydroxymitragynine concentrated at a lev
Introduced January 29, 2026
Community Position
Community Comments
Comment Period
This proposal is not currently open for public comment.